Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Gilead Sciences logo
Gilead SciencesGILD
$56.28B-0.3%
Replimune Group logo
Replimune GroupREPL
$333.59M-44.7%
CG Oncology logo
CG OncologyCGON
$1.14B+55.9%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$95.82M+382%

Other financials

Income statement

See full
Revenue$31.0K0.0%
Operating income-$16.3M-100%
Net income-$8.9M-220%
EPS (diluted)-$0.14-208%

Balance sheet

See full
Cash & equivalents$194.8M+111%
Total debt$2.8M-73.9%
Total equity$138.0M+84.8%

Cash flow

See full
Operating cash flow-$18.0M-109%
CapEx$675.0K+22,400%
Free cash flow-$18.7M-117%

Valuation

See full
Market cap$693.87M+192%
Enterprise value$501.88M+220%
P/S5,595.7×-18,674×

Profitability

See full
Operating margin-28,000.8%+15,050pp
Net margin-15,156.5%-5,064pp
FCF margin-26,383.9%+14,851pp

Returns & leverage

See full
Return on equity-51.2%-16.6pp
Debt / equity-0.1×
Current ratio28×+23.4×

Where this comes from

Reported directly by Candel Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s total assets?
Candel Therapeutics, Inc. (CADL) reported total assets of $201.92M in Q1 2026.
How has Candel Therapeutics, Inc.'s total assets changed year-over-year?
Candel Therapeutics, Inc.'s total assets increased by 110.5% year-over-year, from $95.91M to $201.92M.
What is the long-term trend for Candel Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s total assets has grown at a 26.7% compound annual growth rate (CAGR), from $38.28M to $125.2M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.